Form 4: NeuroPace Director Rakhi Kumar Receives Equity Grant

Director Rakhi Kumar acquired 2,890 shares of common stock and 5,368 stock options in NeuroPace, Inc. as part of a compensation grant.

Summary

• Director Rakhi Kumar was granted 2,890 shares of common stock on June 5, 2026.
• The director also received a stock option grant for 5,368 shares with an exercise price of $15.74.
• Both the common stock and the stock options vest in twelve equal consecutive monthly installments, contingent on continuous service.
• Following these transactions, the director's total beneficial ownership of common stock is 22,050 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Retention mechanism established via a 12-month vesting schedule for both stock and options.

Negatives

• Dilutive impact of new equity grants on existing shareholders, though the scale is minor.

Risks

• Future value of options is dependent on the company's stock price exceeding the $15.74 exercise price.

Future Outlook

The equity grants are subject to a 12-month vesting period, indicating a commitment to ongoing service by the director.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the medical device and biotechnology sectors to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The use of monthly vesting schedules is consistent with standard retention practices for board members in the healthcare technology industry.
• The grant size is typical for a director-level compensation package in a mid-cap medical device company.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor dilution from new equity issuance.
• Director: Increased financial stake in company performance.

Next Steps

• Vesting of shares and options in twelve equal monthly installments.

Key Dates

Keywords

NeuroPace, NPCE, Form 4, Insider Trading, Equity Compensation, Director Compensation